No abstract available
Publication types
-
Clinical Trial, Phase I
-
Letter
-
Randomized Controlled Trial
MeSH terms
-
Administration, Sublingual
-
Animals
-
Aspirin / administration & dosage*
-
Aspirin / adverse effects
-
Aspirin / chemistry
-
Aspirin / pharmacokinetics
-
Biomarkers / blood
-
Biomarkers / urine
-
Collagen / chemistry
-
Double-Blind Method
-
Drug Compounding
-
Fibrinolytic Agents / administration & dosage*
-
Fibrinolytic Agents / adverse effects
-
Fibrinolytic Agents / chemistry
-
Fibrinolytic Agents / pharmacokinetics
-
Gastric Mucosa / drug effects
-
Gastric Mucosa / metabolism
-
Gastric Mucosa / pathology
-
Gastrointestinal Hemorrhage / chemically induced
-
Gastrointestinal Hemorrhage / pathology
-
Gastrointestinal Hemorrhage / prevention & control*
-
Humans
-
Platelet Aggregation Inhibitors / administration & dosage*
-
Platelet Aggregation Inhibitors / adverse effects
-
Platelet Aggregation Inhibitors / chemistry
-
Platelet Aggregation Inhibitors / pharmacokinetics
-
Rats
-
Thromboxane B2 / analogs & derivatives
-
Thromboxane B2 / blood
-
Thromboxane B2 / urine
Substances
-
Biomarkers
-
Fibrinolytic Agents
-
Platelet Aggregation Inhibitors
-
Thromboxane B2
-
11-dehydro-thromboxane B2
-
Collagen
-
Aspirin